[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07014982":3,"trial-entities:NCT07014982":92,"trial-summary:NCT07014982":96},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":20,"study_type":21,"primary_purpose":22,"phases":23,"enrollment_info":25,"interventions":28,"primary_outcomes":34,"secondary_outcomes":45,"sex":57,"minimum_age":58,"maximum_age":17,"healthy_volunteers":59,"eligibility_criteria":60,"std_ages":73,"locations":76,"central_contacts":85,"overall_officials":86,"references":90,"see_also_links":91},"NCT07014982","24-013687","Remote Assessment of Digital Neurologic Testing","Remote Assessment of Digital Neurologic Testing (RADiaNT)","WITHDRAWN","2026-08","2026-09","2026-09-08","2026-07-01","Mayo Clinic","OTHER",false,"The RADiaNT study investigates whether guided meditation, using the Muse™ headband and biofeedback app, can improve sleep, mood, and cognitive performance, aiming to assess its impact on mental and emotional well-being.",null,[19],"Neurology",[19],"INTERVENTIONAL","TREATMENT",[24],"NA",{"count":26,"type":27},0,"ACTUAL",[29],{"type":30,"name":31,"description":32,"armGroupLabels":33},"BEHAVIORAL","Guided Meditation","Participants who complete guided meditation will be asked to meditate for 5 minutes a day, five times a week for two 6-week periods.",[31],[35,39,42],{"measure":36,"description":37,"timeFrame":38},"Duration in slow wave sleep","Total duration of sleep time spent in slow wave sleep (delta), reported in minutes","17 weeks",{"measure":40,"description":41,"timeFrame":38},"Proportion in slow wave sleep","Proportion is the percentage of sleep time spent in slow wave sleep (delta)",{"measure":43,"description":44,"timeFrame":38},"Perceived Stress Scale","Investigators will ask patients to answer the PSS questionnaire at the beginning, interim, and end of the study to see if there were any improvements in sleep quality over the intervention periods. This questionnaire is on a scale that scores 0-40, with the higher the score being a higher level of stress.",[46,49,52,55],{"measure":47,"description":48,"timeFrame":38},"Patient Health Questionnaire 9-item (PHQ-9)","The Patient Health Questionnaire 9-item (PHQ-9) scale used to assess severity of depression. Scoring is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of \"not at all,\" \"several days,\" \"more than half the days,\" and \"nearly every day.\" Total score ranges from 0 to 27 where 0 is no depression, 1-4 is minimal depression, 5-9 is mild depression, 10-14 is moderate depression, and 15-19 is moderately severe depression and 20-27 severe depression.",{"measure":50,"description":51,"timeFrame":38},"General Anxiety Disorder 7-item (GAD-7)","The General Anxiety Disorder 7-item (GAD 7) scale to assess severity of generalized anxiety disorder. Scoring is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of \"not at all,\" \"several days,\" \"more than half the days,\" and \"nearly every day.\" Total score for the seven items ranges from 0 to 21 where 0 is no anxiety, 1-4 is minimal anxiety, 5-9 is mild anxiety, 10-14 is moderate anxiety, and 15-21 is severe anxiety.",{"measure":53,"description":54,"timeFrame":38},"Cognitive Performance","Investigators will test patients' cognitive performance at the beginning, interim, and conclusion of the study using Mayo Speech Test.",{"measure":53,"description":56,"timeFrame":38},"Investigators will test patients' cognitive performance at the beginning, interim, and conclusion of the study using Mayo Test Drive.","ALL","18 Years",true,{"inclusion":61,"exclusion":67,"raw_text":72},[62,63,64,65,66],"Cognition unimpaired or mild cognitive impairment","Fluent in English","United States resident","Able to tolerate wearing Muse headband","basic competence in using electronic devices (Smartphone or tablet) to engage with the Muse application and complete digital surveys and assessments",[68,69,70,71],"Neurological and Brain Disorders","Not Fluent in English","Not a US Resident","Unable to tolerate wearing Muse Headband","Inclusion Criteria:\n\n* Cognition unimpaired or mild cognitive impairment\n* Fluent in English\n* United States resident\n* Able to tolerate wearing Muse headband\n* basic competence in using electronic devices (Smartphone or tablet) to engage with the Muse application and complete digital surveys and assessments\n\nExclusion Criteria:\n\n* Neurological and Brain Disorders\n* Not Fluent in English\n* Not a US Resident\n* Unable to tolerate wearing Muse Headband",[74,75],"ADULT","OLDER_ADULT",[77],{"facility":13,"city":78,"state":79,"zip":80,"country":81,"geoPoint":82},"Rochester","Minnesota","55905","United States",{"lat":83,"lon":84},44.02163,-92.4699,[],[87],{"name":88,"affiliation":13,"role":89},"David Jones, MD","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":93,"biomarkers":95},[94],"Cognitive Dysfunction",[],{"nct_id":4,"found":59,"summary":97,"prompt_version":107},{"design":98,"status":99,"heading":100,"summary":101,"follow_up":102,"word_count":103,"commitments":104,"compensation":105,"drugs_mentioned":106},"This interventional study plans to enroll 40 participants. It is not specified if it is randomized or blinded.","completed","Remote Assessment of Digital Neurologic Testing (RADiaNT) Study","This study, called RADiaNT, is looking into whether guided meditation can improve sleep, mood, and thinking skills. You would use a special headband (Muse™) and app for guided meditation. The study is open to adults aged 18 and older who live in the United States, speak English fluently, and can use electronic devices. You should also have unimpaired thinking or only mild cognitive impairment. Researchers will measure how long you spend in deep sleep, the proportion of time you spend in deep sleep, and your perceived stress levels after 17 weeks to see if the meditation helps. The current status of this study is unclear.","The primary endpoints are measured at 17 weeks, suggesting follow-up until at least this time point.",105,"Participants will be asked to meditate for 5 minutes a day, five times a week, for two 6-week periods. You will also need to use a smartphone or tablet for the Muse application and to complete digital surveys.","Not stated in the trial record.",[31],"v2"]